cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas-Reference-Cited by-同舟云学术

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

Published:2020-01-29 Issue:3 Volume:139 Page:603-608
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Brat Daniel J.,Aldape Kenneth,Colman Howard,Figrarella-Branger Dominique,Fuller Gregory N.,Giannini Caterina,Holland Eric C.,Jenkins Robert B.,Kleinschmidt-DeMasters Bette,Komori Takashi,Kros Johan M.,Louis David N.,McLean Catriona,Perry Arie,Reifenberger Guido,Sarkar Chitra,Stupp Roger,van den Bent Martin J.,von Deimling Andreas,Weller Michael

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00401-020-02127-9.pdf

Reference33 articles.

1. Aoki K, Nakamura H, Suzuki H, Matsuo K, Kataoka K, Shimamura T et al (2018) Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro Oncol 20:66–77. https://doi.org/10.1093/neuonc/nox132

2. Appay R, Dehais C, Maurage C-A, Alentorn A, Carpentier C, Colin C et al (2019) CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. Neuro Oncol 21:1519–1528. https://doi.org/10.1093/neuonc/noz124

3. Brand F, Forster A, Christians A, Bucher M, Thome CM, Raab MS et al (2020) FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas. Acta Neuropathol 139:175–192. https://doi.org/10.1007/s00401-019-02067-z

4. Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB et al (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”. Acta Neuropathol 136:805–810. https://doi.org/10.1007/s00401-018-1913-0

5. Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. https://doi.org/10.1056/NEJMoa1402121

Cited by 378 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical diagnosis of CNS tumors according to WHO CNS 2021 classification: General changes and diagnosis of diffuse gliomas;Neurologie pro praxi;2024-09-10

2. Clinical sequencing reveals diagnostic, therapeutic, and prognostic biomarkers for adult-type diffuse gliomas;Heliyon;2024-09

3. T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant;Neurosurgical Review;2024-08-09

4. Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance;Journal of Neuro-Oncology;2024-08-08

5. Daily management of gliomas, glioneuronal, and neuronal tumors in the era of the 2021 WHO classification of nervous tumors;Frontiers in Neurology;2024-07-29